Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase
NCT00369187
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
large protein molecule
Sponsor
Halozyme Therapeutics